Avandia risk higher than other diabetes drugs
A study published in the Archives of Internal Medicine, conducted in Boston, indicates that those people aged 65 or over who took Avandia faced a 15 per cent increased risk of death after one year, not to mention a 13 per cent greater risk of heart failure.
Dr. Wolfgang Winkelmayer was reported as saying: "For me, that left an important question open. What if you happen to directly compare those two treatments together?"
The study authors reportedly concluded: "Although previous studies have indicated that the increased risk with rosiglitazone use resides predominantly in cardiovascular outcomes, the present study suggests that differences in all-cause mortality [death] risk may be even more important to consider in elderly patients."
Also related to this storyDiabetes newsletter
Diabetes based financial services
Diabetes hampers for Christmas
Diabetes care in Norfolk concerning
Diabetes day highlighted by building
Avandia has a diabetes drug competitor
Avandia treats and prevents diabetes
Stiff FDA warning from Avandia
Diabetics on Avandia likely to be switched to Januvia or Byetta